Nasdaq notifies Petros Pharmaceuticals of common stock delisting effective Nov 7, 2025

Petros Pharmaceuticals, Inc.

Nasdaq notified Petros on Nov 3, 2025, of intention to delist common stock on Nov 7, 2025.
Stock suspended from Nasdaq Capital Market on May 22, 2025; trading on OTCID since July 1, 2025.
Nasdaq to file Form 25 to deregister stock under Section 12(b); delisting effective 10 days later.
Common stock continues trading on OTCID symbol PTPI without disruption; SEC reporting obligations remain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.